Company Profile and Overview: IQVIA
IQVIA is a leading global provider of advanced analytics, technology solutions, and professional services to the life sciences industry. The company was founded in 2016 through the merger of IMS Health and Quintiles, two of the world’s largest healthcare data and services companies. The merger marked the beginning of a new era in healthcare, combining the strengths of both organizations to create a more powerful and innovative force in the industry.
IMS Health was originally founded in 1954 by Bill Frohlich and David Dubow as Intercontinental Marketing Services. Over the years, the company grew and evolved, becoming a key player in the healthcare data and analytics space. Quintiles, on the other hand, was founded in 1982 by Dennis Gillings and became a prominent contract research organization (CRO) offering clinical, commercial, consulting, and capital solutions to the pharmaceutical and life sciences industries.
The merger of IMS Health and Quintiles in 2016 led to the formation of IQVIA, a company with a global footprint and the ability to offer end-to-end solutions for the life sciences industry. With a rich history and a strong foundation in healthcare data, technology, and services, IQVIA has continued to shape the future of healthcare through its innovative solutions and deep industry expertise.
The co-founders of IQVIA have played key roles in shaping the company’s vision, strategy, and culture. Bill Frohlich and David Dubow, the co-founders of IMS Health, brought together a deep understanding of healthcare data and analytics, laying the groundwork for the company’s future success. Their commitment to innovation and excellence set the stage for IMS Health’s growth and ultimately paved the way for the merger with Quintiles.
Dennis Gillings, the founder of Quintiles, is a renowned figure in the pharmaceutical and life sciences industries. His vision and leadership have been instrumental in positioning Quintiles as a global leader in clinical research and healthcare solutions. Under his guidance, Quintiles became a trusted partner for pharmaceutical and biotechnology companies, delivering valuable insights and services to support their research and development efforts.
The combined expertise and leadership of the co-founders of IMS Health and Quintiles have been integral to the success of IQVIA. Their vision and commitment to excellence have set the company on a path of continued innovation and growth, driving value for clients and stakeholders across the healthcare ecosystem.
IQVIA is headquartered in Durham, North Carolina, with a global presence spanning more than 100 countries. The company’s headquarters in Durham serves as a hub for its diverse portfolio of services, including advanced analytics, technology solutions, and consulting services for the life sciences industry.
With a strategic location in the Research Triangle Park region, IQVIA’s headquarters in Durham is at the heart of a thriving ecosystem of innovation and collaboration. The company’s presence in this dynamic area has enabled it to cultivate strong partnerships with leading academic institutions, research organizations, and healthcare companies, further enhancing its ability to drive groundbreaking advancements in healthcare.
In addition to its headquarters in Durham, IQVIA has a network of offices and operations around the world, strengthening its global reach and impact. From Europe to Asia to Latin America, IQVIA’s presence in key markets allows it to deliver comprehensive solutions and services to clients across the entire spectrum of the healthcare industry. The company’s commitment to excellence and innovation is reflected in its global headquarters and its ongoing efforts to shape the future of healthcare on a global scale.
In conclusion, IQVIA is a leading global provider of advanced analytics, technology solutions, and professional services to the life sciences industry. The company’s history, founders, and headquarters all play integral roles in shaping its vision, strategy, and impact. With a rich heritage and a global presence, IQVIA continues to drive innovation and excellence in the healthcare industry, helping to shape the future of healthcare for the better.
IQVIA is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company specializes in utilizing data, technology, and expert insights to help biotech, pharmaceutical, and medical device companies accelerate the development and commercialization of innovative therapies and medications. With a diverse array of offerings, IQVIA supports clients at every stage of the drug development and commercialization process, from clinical trial design and execution to market access, sales, and marketing.
IQVIA operates in over 100 countries and employs more than 70,000 professionals worldwide. The company is committed to driving healthcare forward by helping clients navigate complex regulatory environments, access and leverage real-world data, and optimize their operations to deliver better patient outcomes.
With a comprehensive suite of products and services, IQVIA offers a holistic approach to supporting the life sciences industry. Its product portfolio includes innovative technology solutions, advanced analytics, consulting services, and patient recruitment and engagement strategies. The company’s offerings are designed to help clients make informed decisions, streamline their operations, and ultimately bring life-saving healthcare products to market more efficiently.
IQVIA’s technology solutions encompass a wide range of applications, including data management, advanced analytics, patient recruitment, and commercialization tools. Its consulting services focus on providing strategic insights and expert guidance to help clients optimize their drug development and commercialization strategies. Additionally, IQVIA’s patient recruitment and engagement strategies leverage data and technology to identify and engage potential clinical trial participants, ultimately accelerating the drug development process.
Relevance in the Field
In today’s rapidly evolving healthcare landscape, IQVIA plays a critical role in helping life sciences companies navigate complex challenges and capitalize on new opportunities. The company’s innovative approach to leveraging data, technology, and expertise has made it a trusted partner for biotech, pharmaceutical, and medical device companies around the world.
IQVIA’s relevance in the field is underscored by its ability to provide actionable insights and solutions that enable clients to make informed decisions and drive better outcomes for patients. By combining real-world evidence, advanced analytics, and deep industry expertise, IQVIA empowers its clients to bring life-saving therapies to market more efficiently and effectively.
As a leader in the life sciences industry, IQVIA is constantly at the forefront of major trends and developments that impact healthcare and drug development. The company regularly publishes insights, research reports, and thought leadership pieces that provide valuable perspectives on industry trends, regulatory changes, and emerging technologies.
IQVIA’s insights are informed by its extensive experience working with clients across the globe and its deep understanding of the nuances of the healthcare industry. By staying ahead of the curve and offering thought-provoking insights, IQVIA helps its clients stay informed and prepared to navigate the complexities of the healthcare landscape.
|Founded||2016 (merger of IMS Health and Quintiles)|
|# of Employees||Over 70,000|
|Sector||Healthcare and Life Sciences|
|Main Products||Advanced analytics, technology solutions, contract research services|
|Revenue||$11.4 billion (2020)|
|Headquarters||Durham, North Carolina, USA|
|Countries||Operations in over 100 countries|